Search All News
Please join in welcoming Dr. Robert J. Wechsler-Reya to the department.
Students from historically Black colleges and universities (HBCUs) joined Columbia biomedical research laboratories for a summer of science, as part of CUIMC’s newest summer program
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer’s disease.
A new initiative led by Columbia University and the n-Lorem Foundation will develop personalized therapies for individuals with "nano-rare" genetic forms of ALS and treat them for free, for life.
- June 10, 2021
Drs. Bell and Ader will conduct a feasibility study titled, "Intervention to capture the diagnostic potential of individuals in a group-based learning or clinical environment."
Source:CUIMC NewsroomFebruary 8, 2021
Cells used to study the human blood brain barrier in the lab aren’t what they seem, throwing nearly a decade’s worth of research into question
- January 31, 2021
Please join in welcoming Dr. Yalda Moayedi-Esfahani to the department.
Source:ForbesNovember 10, 2020
Philip De Jager, a neurologist at Columbia University in New York, investigated what epigenetic changes occurred in the presence of tau tangles.
Source:CUIMC NewsroomJuly 29, 2020
Researchers at Columbia University Irving Medical Center have developed eye drops that could prevent vision loss after retinal vein occlusion.
Source:Science MagazineJuly 8, 2020
Researchers have converted a bacterial toxin into a genome editing tool that, for the first time, can make precise changes to DNA in mitochondria, the cell’s power plants.
Source:Oprah MagazineJune 24, 2020
The Alzheimer’s epidemic no one is talking about. That’s where the work of Jennifer J. Manly, PhD, a professor of neuropsychology at Columbia University Irving Medical Center, comes in.